Company Takara Bio Inc. Deutsche Boerse AG

Equities

TF2

JP3460200003

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Takara Bio Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG Other stock markets 01:20:00 18/07/2024 am IST			5-day change	1st Jan Change
6.55 ^EUR	+0.77%		+5.65%	-14.94%

18/03	Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	CI
15/02	Takara Bio's Attributable Income Falls 98.9% in Fiscal Nine Months	MT

TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Number of employees: 1,838

JPY in Million	2023	Weight	2024	Weight	Delta
Reagent 73.5 %	65,925	84.4 %	31,961	73.5 %	-51.52%
Brokerage 18.4 %	8,200	10.5 %	7,997	18.4 %	-2.48%
Genetic Medicine 6.1 %	2,640	3.4 %	2,653	6.1 %	+0.49%
Equipment 2.1 %	1,375	1.8 %	892	2.1 %	-35.13%

JPY in Million	2023	Weight	2024	Weight	Delta
Japan 35.5 %	45,667	58.4 %	15,434	35.5 %	-66.20%
United States 29.8 %	12,886	16.5 %	12,974	29.8 %	+0.68%
China 16.2 %	10,799	13.8 %	7,039	16.2 %	-34.82%
Europe 10.3 %	4,949	6.3 %	4,496	10.3 %	-9.15%
Asia excluding Japan and China 7.7 %	3,546	4.5 %	3,355	7.7 %	-5.39%
Others 0.5 %	293	0.4 %	205	0.5 %	-30.03%

Managers	Title	Age	Since
Shuichiro Matsuzaki DFI	Director of Finance/CFO	68	01/14/01
Koichi Nakao PSD	President	62	01/02/01
Takuya Kakemi ADM	Chief Administrative Officer	-	-
Junichi Mineno COO	Chief Operating Officer	63	01/04/01
Tsuyoshi Miyamura BRD	Director/Board Member	60	01/09/01
Masanobu Kimura BRD	Director/Board Member	60	01/13/01
Noritaka Nishiwaki HRO	Human Resources Officer	-	-
Akihiko Kita AUD	Comptroller/Controller/Auditor	64	01/05/01
Masanari Kitagawa PRN	Corporate Officer/Principal	-	-
Masahide Tamaki AUD	Comptroller/Controller/Auditor	64	01/05/01

Members of the board	Title	Age	Since
Hisashi Omiya CHM	Chairman	81	01/02/01
Masanobu Kimura BRD	Director/Board Member	60	01/13/01
Koichi Nakao PSD	President	62	01/02/01
Shuichiro Matsuzaki DFI	Director of Finance/CFO	68	01/14/01
Tsuyoshi Miyamura BRD	Director/Board Member	60	01/09/01
Junichi Mineno COO	Chief Operating Officer	63	01/04/01
Kazuko Kimura BRD	Director/Board Member	73	01/19/01
Nobuko Kawashima BRD	Director/Board Member	61	01/16/01
Noriomi Matsumura BRD	Director/Board Member	53	01/20/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	120,415,600	47,065,600 ( 39.09 %)	0	39.09 %

Name	Equities	%	Valuation
AllianceBernstein Ltd. 0.2733 %	329,100	0.2733 %	2 M €
Sumitomo Mitsui Trust Asset Management Co., Ltd. 0.0651 %	78,400	0.0651 %	538 068 €
DJE Kapital AG 0.0558 %	67,227	0.0558 %	461 386 €
SBI Okasan Asset Management Co. Ltd. 0.0188 %	22,600	0.0188 %	155 106 €
Mercer Global Investments Europe Ltd. 0.0152 %	18,300	0.0152 %	125 595 €
Resona Asset Management Co., Ltd. 0.008305 %	10,000	0.008305 %	68 631 €
KLP Kapitalforvaltning AS 0.007557 %	9,100	0.007557 %	62 454 €
BlackRock International Ltd. 0.005149 %	6,200	0.005149 %	42 551 €
State Street Global Advisors (Japan) Co. Ltd. 0.003986 %	4,800	0.003986 %	32 943 €
State Street Global Advisors Ltd. 0.002437 %	2,934	0.002437 %	20 136 €

Takara Bio, Inc.

7-4-38 Nojihigashi

525-0058, Kusatsu

+81 77 565 6920

http://www.takara-bio.co.jp

Name	Category and Sector
Cellectis AB Cellectis AB BiotechnologyHealth Technology Part of Takara Holdings, Inc., Cellectis AB is a Swedish company that manufactures and distributes stem cell-related products. The company is based in Gothenburg, Sweden. Cellectis was acquired by Takara Bio, Inc. from Cellectis SA on September 04, 2014.	Biotechnology
Takara Bio Europe SAS Takara Bio Europe SAS Medical SpecialtiesHealth Technology Takara BIO Europe SAS provides kits, reagents, instruments, and services that enable life sciences researchers to achieve their experimental objectives. It offers automation systems, stem cell research, real time PCR, nucleic acid purification, cloning, cell biology assays, gene function, antibodies, and ELISAs. The company is headquartered in Saint-Germain-en-Laye, France.	Medical Specialties

Name

Category and Sector

Biotechnology

Medical Specialties

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,176 JPY

Average target price

1,567 JPY

Spread / Average Target

+33.22%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+24.74%	47.96B
IQVIA HOLDINGS INC.	-0.47%	42.45B
LONZA GROUP AG	+43.96%	41.47B
ALNYLAM PHARMACEUTICALS, INC.	+25.40%	31.6B
ICON PUBLIC LIMITED COMPANY	+17.96%	28.63B
CELLTRION, INC.	-4.47%	28.03B
UNITED THERAPEUTICS CORPORATION	+50.73%	14.56B
MEDPACE HOLDINGS, INC.	+42.56%	14.14B
BIO-TECHNE CORPORATION	+1.46%	12.58B

Other Biotechnology & Medical Research